Neoadjuvant, biweekly, dose-dense chemotherapy with epirubicin and cyclophoshamid followed by docetaxel in primary breast cancer

被引：0
|
作者：
Cramer, EM [1 ]
Moers, C [1 ]
Zarghooni, V [1 ]
Bosse, K [1 ]
Mallmann, P [1 ]
Warm, M [1 ]
机构：
[1] Univ Cologne, Fac Med, Cologne, Germany
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2005年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S231 / S231
页数：1
相关论文
共 50 条
  • [1] Neoadjuvant, biweekly, dose-dense chemotherapy with epirubicin and cyclophosphamide followed by docetaxel in primary breast cancer.
    Cramer, EM
    Moers, C
    Zarghooni, V
    Mallmann, P
    Warm, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 82S - 82S
  • [2] Neoadjuvant dose-dense sequential biweekly epirubicin and cyclophosphamide followed by docetaxel and trastuzumab for HER2+operable breast cancer
    Blakely, L.
    Somer, B.
    Keaton, M.
    Hermann, R.
    Schnell, F.
    Cobb, P.
    Johns, A.
    Walker, M.
    Schwartzberg, L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [3] Neoadjuvant biweekly dose-dense chemotherapy with fluouracil, epirubicin, and cyclophosphamide (FEC 90), followed by docetaxel in patients with HER2-neu negative primary breast cancer
    Rodriguez-Abreu, D.
    Murias, A.
    Garcia, M.
    Vega, V.
    Garcia, C.
    Mori, M.
    Baez-Acosta, B.
    Diez, A.
    Almenarez, J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [4] Preoperative dose-dense sequential chemotherapy of epirubicin/cyclophosphamide followed by docetaxel/capecitabine in patients with breast cancer
    Grassadonia, Antonino
    Cianchetti, Ettore
    Ficorella, Corrado
    Angelucci, Domenico
    Grossi, Simona
    Ricevuto, Enrico
    Zilli, Marinella
    Tinari, Nicola
    Natoli, Clara
    Iacobelli, Stefano
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 97 - 97
  • [5] Dose-Dense Epirubicin and Cyclophosphamide Followed by Docetaxel as Adjuvant Chemotherapy in Node-Positive Breast Cancer
    Mirzaei, Hamid Reza
    Rasekh, Parisa Sabet
    Nasrollahi, Fatemeh
    Rasekh, Parto Sabet
    Tirabad, Zahra Akbari
    RezaMoein, Hamid
    Pour, Taban Ghaffari
    Hajian, Parastoo
    [J]. INTERNATIONAL JOURNAL OF BREAST CANCER, 2013, 2013
  • [6] Preoperative dose-dense sequential chemotherapy of epirubicin/cyclophosphamide followed by docetaxel/capecitabine in patients with breast cancer.
    Natoli, C.
    Cianchetti, E.
    Ficorella, C.
    Angelucci, D.
    Grossi, S.
    Noccioli, P.
    Ricevuto, E.
    Grassadonia, A.
    Zilli, M.
    Di Giacobbe, A.
    Rispoli, A., I
    Tinari, N.
    Iacobelli, S.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S150 - S150
  • [7] Primary dose-dense epirubicin/cyclophosphamide→docetaxel in breast cancer: preliminary results
    Cocciolone, V.
    Cannita, K.
    Bruera, G.
    Bafile, A.
    Coletti, G.
    Resta, V.
    Ciccozzi, A.
    Dalmas, A.
    Ficorella, C.
    Ricevuto, E.
    [J]. BREAST, 2015, 24 : S100 - S101
  • [8] Efficacy of pegfilgrastim to support neoadjuvant dose-dense epirubicin and cyclophosphamide chemotherapy in breast cancer
    Xinguang Wang
    Yingjian He
    Tianfeng Wang
    Yuntao Xie
    Jinfeng Li
    Tao Ouyang
    Zhaoqing Fan
    [J]. Supportive Care in Cancer, 2019, 27 : 3019 - 3025
  • [9] Efficacy of pegfilgrastim to support neoadjuvant dose-dense epirubicin and cyclophosphamide chemotherapy in breast cancer
    Wang, Xinguang
    He, Yingjian
    Wang, Tianfeng
    Xie, Yuntao
    Li, Jinfeng
    Ouyang, Tao
    Fan, Zhaoqing
    [J]. SUPPORTIVE CARE IN CANCER, 2019, 27 (08) : 3019 - 3025
  • [10] Efficacy and safety of dose-dense neoadjuvant chemotherapy with nab-paclitaxel followed by epirubicin and cyclophosphamide for operable breast cancer
    Matsumoto, Akiko
    Jinno, Hiromitsu
    Naruse, Saki
    Isono, Yuka
    Maeda, Yuka
    Sato, Ayana
    Yamada, Miki
    Ikeda, Tatsuhiko
    Sasajima, Yuko
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2023, 53 (12) : 1119 - 1124
12345